GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion

1  Department of Urology, Kanazawa University School of Medicine, and 2  Department of Pharmacology and Pharmaceutics, Graduate School of Natural Science and Technology, Kanazawa University, Ishikawa 920-8641, Japan To evaluate the influences of -aminobutyric acid (GABA) mechanisms on bladder hypera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2000-10, Vol.279 (4), p.1230-R1238
Hauptverfasser: Kanie, Sayoko, Yokoyama, Osamu, Komatsu, Kazuto, Kodama, Koichi, Yotsuyanagi, Satoshi, Niikura, Susumu, Nagasaka, Yasuhiro, Miyamoto, Ken-Ichi, Namiki, Mikio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page R1238
container_issue 4
container_start_page 1230
container_title American journal of physiology. Regulatory, integrative and comparative physiology
container_volume 279
creator Kanie, Sayoko
Yokoyama, Osamu
Komatsu, Kazuto
Kodama, Koichi
Yotsuyanagi, Satoshi
Niikura, Susumu
Nagasaka, Yasuhiro
Miyamoto, Ken-Ichi
Namiki, Mikio
description 1  Department of Urology, Kanazawa University School of Medicine, and 2  Department of Pharmacology and Pharmaceutics, Graduate School of Natural Science and Technology, Kanazawa University, Ishikawa 920-8641, Japan To evaluate the influences of -aminobutyric acid (GABA) mechanisms on bladder hyperactivity after left middle cerebral artery occlusion, cystometric recordings were obtained from unanesthetized female rats. Intracerebroventricular administration of both muscimol (GABA A receptor agonist; 0.1-10 nmol) and baclofen (GABA B receptor agonist; 0.1-3 nmol) produced dose-dependent inhibitions of micturition with increases in bladder capacity (BC). The effects of high doses (1-10 nmol) were similar in sham-operated (SO) and cerebral-infarcted (CI) rats. However, lower doses of muscimol (0.1 or 0.3 nmol) and baclofen (0.1 nmol) reduced BC in CI rats. After bicuculline (GABA A receptor antagonist; 1 or 3 nmol) administration, BC in both SO and CI rats first decreased and subsequently increased. An increase in urethral pressure was observed after administration of bicuculline (3 nmol) but not with either muscimol or baclofen. Infarct volumes in muscimol-, bicuculline-, or baclofen-treated rats were not significantly different from those of vehicle-treated rats. These results suggest that GABAergic mechanisms inhibit the micturition reflex at the supraspinal level but that this can change as a result of CI. GABA or -aminobutyric acid; micturition reflex; cerebral infarction
doi_str_mv 10.1152/ajpregu.2000.279.4.r1230
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_11003988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72293182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-bdc97e709ff5665793f00b7a56bee2c9bd73f05535d35d03d17199ef9e46e86b3</originalsourceid><addsrcrecordid>eNp1kF1rFDEYhYModlv9C5Ir72aaj5nJxLu1tFUoCNLe9Cbk453dlOzOmGS08-_NsivVCyEQODnPCTwIYUpqSlt2qZ-mCJu5ZoSQmglZN3WkjJNXaFWeWUUbSV6jFeEdrzpK5Rk6T-mplBve8LfojFJCuOz7FXq8XX9eQ9x4i-24z9GbOftxj_OIo87YBO0cRLxdJojaZv_T5wXrIZds550LgC1EMFEHrGNJFzxaG-ZUNt6hN4MOCd6f7gv0cHN9f_Wluvt2-_VqfVfZphO5Ms5KAYLIYWi7rhWSD4QYodvOADArjRMlaVveunIId1RQKWGQ0HTQd4ZfoI_H3SmOP2ZIWe18shCC3sM4JyUYk5z2rBT7Y9HGMaUIg5qi3-m4KErUwas6eVUHr6p4VY36fvBa0A-nP2azA_cCnkSWQn0sbP1m-8tHUNN2KRbCuFleZv9Z_PR_4GYO4R6e8x_yL1BNbuC_AY6bnZ8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72293182</pqid></control><display><type>article</type><title>GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kanie, Sayoko ; Yokoyama, Osamu ; Komatsu, Kazuto ; Kodama, Koichi ; Yotsuyanagi, Satoshi ; Niikura, Susumu ; Nagasaka, Yasuhiro ; Miyamoto, Ken-Ichi ; Namiki, Mikio</creator><creatorcontrib>Kanie, Sayoko ; Yokoyama, Osamu ; Komatsu, Kazuto ; Kodama, Koichi ; Yotsuyanagi, Satoshi ; Niikura, Susumu ; Nagasaka, Yasuhiro ; Miyamoto, Ken-Ichi ; Namiki, Mikio</creatorcontrib><description>1  Department of Urology, Kanazawa University School of Medicine, and 2  Department of Pharmacology and Pharmaceutics, Graduate School of Natural Science and Technology, Kanazawa University, Ishikawa 920-8641, Japan To evaluate the influences of -aminobutyric acid (GABA) mechanisms on bladder hyperactivity after left middle cerebral artery occlusion, cystometric recordings were obtained from unanesthetized female rats. Intracerebroventricular administration of both muscimol (GABA A receptor agonist; 0.1-10 nmol) and baclofen (GABA B receptor agonist; 0.1-3 nmol) produced dose-dependent inhibitions of micturition with increases in bladder capacity (BC). The effects of high doses (1-10 nmol) were similar in sham-operated (SO) and cerebral-infarcted (CI) rats. However, lower doses of muscimol (0.1 or 0.3 nmol) and baclofen (0.1 nmol) reduced BC in CI rats. After bicuculline (GABA A receptor antagonist; 1 or 3 nmol) administration, BC in both SO and CI rats first decreased and subsequently increased. An increase in urethral pressure was observed after administration of bicuculline (3 nmol) but not with either muscimol or baclofen. Infarct volumes in muscimol-, bicuculline-, or baclofen-treated rats were not significantly different from those of vehicle-treated rats. These results suggest that GABAergic mechanisms inhibit the micturition reflex at the supraspinal level but that this can change as a result of CI. GABA or -aminobutyric acid; micturition reflex; cerebral infarction</description><identifier>ISSN: 0363-6119</identifier><identifier>EISSN: 1522-1490</identifier><identifier>DOI: 10.1152/ajpregu.2000.279.4.r1230</identifier><identifier>PMID: 11003988</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Baclofen - administration &amp; dosage ; Baclofen - pharmacology ; Bicuculline - administration &amp; dosage ; Bicuculline - pharmacology ; Cerebral Infarction - physiopathology ; Cerebral Ventricles - drug effects ; Cerebral Ventricles - physiology ; Cerebral Ventricles - physiopathology ; Dose-Response Relationship, Drug ; Female ; GABA-A Receptor Agonists ; GABA-B Receptor Agonists ; Injections, Intraventricular ; Middle Cerebral Artery - physiology ; Muscimol - administration &amp; dosage ; Muscimol - pharmacology ; Pressure ; Rats ; Rats, Sprague-Dawley ; Seizures - physiopathology ; Urinary Bladder - drug effects ; Urinary Bladder - physiology ; Urinary Bladder - physiopathology ; Urination - drug effects ; Urination - physiology</subject><ispartof>American journal of physiology. Regulatory, integrative and comparative physiology, 2000-10, Vol.279 (4), p.1230-R1238</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-bdc97e709ff5665793f00b7a56bee2c9bd73f05535d35d03d17199ef9e46e86b3</citedby><cites>FETCH-LOGICAL-c467t-bdc97e709ff5665793f00b7a56bee2c9bd73f05535d35d03d17199ef9e46e86b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,3026,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11003988$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kanie, Sayoko</creatorcontrib><creatorcontrib>Yokoyama, Osamu</creatorcontrib><creatorcontrib>Komatsu, Kazuto</creatorcontrib><creatorcontrib>Kodama, Koichi</creatorcontrib><creatorcontrib>Yotsuyanagi, Satoshi</creatorcontrib><creatorcontrib>Niikura, Susumu</creatorcontrib><creatorcontrib>Nagasaka, Yasuhiro</creatorcontrib><creatorcontrib>Miyamoto, Ken-Ichi</creatorcontrib><creatorcontrib>Namiki, Mikio</creatorcontrib><title>GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion</title><title>American journal of physiology. Regulatory, integrative and comparative physiology</title><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><description>1  Department of Urology, Kanazawa University School of Medicine, and 2  Department of Pharmacology and Pharmaceutics, Graduate School of Natural Science and Technology, Kanazawa University, Ishikawa 920-8641, Japan To evaluate the influences of -aminobutyric acid (GABA) mechanisms on bladder hyperactivity after left middle cerebral artery occlusion, cystometric recordings were obtained from unanesthetized female rats. Intracerebroventricular administration of both muscimol (GABA A receptor agonist; 0.1-10 nmol) and baclofen (GABA B receptor agonist; 0.1-3 nmol) produced dose-dependent inhibitions of micturition with increases in bladder capacity (BC). The effects of high doses (1-10 nmol) were similar in sham-operated (SO) and cerebral-infarcted (CI) rats. However, lower doses of muscimol (0.1 or 0.3 nmol) and baclofen (0.1 nmol) reduced BC in CI rats. After bicuculline (GABA A receptor antagonist; 1 or 3 nmol) administration, BC in both SO and CI rats first decreased and subsequently increased. An increase in urethral pressure was observed after administration of bicuculline (3 nmol) but not with either muscimol or baclofen. Infarct volumes in muscimol-, bicuculline-, or baclofen-treated rats were not significantly different from those of vehicle-treated rats. These results suggest that GABAergic mechanisms inhibit the micturition reflex at the supraspinal level but that this can change as a result of CI. GABA or -aminobutyric acid; micturition reflex; cerebral infarction</description><subject>Animals</subject><subject>Baclofen - administration &amp; dosage</subject><subject>Baclofen - pharmacology</subject><subject>Bicuculline - administration &amp; dosage</subject><subject>Bicuculline - pharmacology</subject><subject>Cerebral Infarction - physiopathology</subject><subject>Cerebral Ventricles - drug effects</subject><subject>Cerebral Ventricles - physiology</subject><subject>Cerebral Ventricles - physiopathology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>GABA-A Receptor Agonists</subject><subject>GABA-B Receptor Agonists</subject><subject>Injections, Intraventricular</subject><subject>Middle Cerebral Artery - physiology</subject><subject>Muscimol - administration &amp; dosage</subject><subject>Muscimol - pharmacology</subject><subject>Pressure</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Seizures - physiopathology</subject><subject>Urinary Bladder - drug effects</subject><subject>Urinary Bladder - physiology</subject><subject>Urinary Bladder - physiopathology</subject><subject>Urination - drug effects</subject><subject>Urination - physiology</subject><issn>0363-6119</issn><issn>1522-1490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kF1rFDEYhYModlv9C5Ir72aaj5nJxLu1tFUoCNLe9Cbk453dlOzOmGS08-_NsivVCyEQODnPCTwIYUpqSlt2qZ-mCJu5ZoSQmglZN3WkjJNXaFWeWUUbSV6jFeEdrzpK5Rk6T-mplBve8LfojFJCuOz7FXq8XX9eQ9x4i-24z9GbOftxj_OIo87YBO0cRLxdJojaZv_T5wXrIZds550LgC1EMFEHrGNJFzxaG-ZUNt6hN4MOCd6f7gv0cHN9f_Wluvt2-_VqfVfZphO5Ms5KAYLIYWi7rhWSD4QYodvOADArjRMlaVveunIId1RQKWGQ0HTQd4ZfoI_H3SmOP2ZIWe18shCC3sM4JyUYk5z2rBT7Y9HGMaUIg5qi3-m4KErUwas6eVUHr6p4VY36fvBa0A-nP2azA_cCnkSWQn0sbP1m-8tHUNN2KRbCuFleZv9Z_PR_4GYO4R6e8x_yL1BNbuC_AY6bnZ8</recordid><startdate>20001001</startdate><enddate>20001001</enddate><creator>Kanie, Sayoko</creator><creator>Yokoyama, Osamu</creator><creator>Komatsu, Kazuto</creator><creator>Kodama, Koichi</creator><creator>Yotsuyanagi, Satoshi</creator><creator>Niikura, Susumu</creator><creator>Nagasaka, Yasuhiro</creator><creator>Miyamoto, Ken-Ichi</creator><creator>Namiki, Mikio</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001001</creationdate><title>GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion</title><author>Kanie, Sayoko ; Yokoyama, Osamu ; Komatsu, Kazuto ; Kodama, Koichi ; Yotsuyanagi, Satoshi ; Niikura, Susumu ; Nagasaka, Yasuhiro ; Miyamoto, Ken-Ichi ; Namiki, Mikio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-bdc97e709ff5665793f00b7a56bee2c9bd73f05535d35d03d17199ef9e46e86b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Baclofen - administration &amp; dosage</topic><topic>Baclofen - pharmacology</topic><topic>Bicuculline - administration &amp; dosage</topic><topic>Bicuculline - pharmacology</topic><topic>Cerebral Infarction - physiopathology</topic><topic>Cerebral Ventricles - drug effects</topic><topic>Cerebral Ventricles - physiology</topic><topic>Cerebral Ventricles - physiopathology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>GABA-A Receptor Agonists</topic><topic>GABA-B Receptor Agonists</topic><topic>Injections, Intraventricular</topic><topic>Middle Cerebral Artery - physiology</topic><topic>Muscimol - administration &amp; dosage</topic><topic>Muscimol - pharmacology</topic><topic>Pressure</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Seizures - physiopathology</topic><topic>Urinary Bladder - drug effects</topic><topic>Urinary Bladder - physiology</topic><topic>Urinary Bladder - physiopathology</topic><topic>Urination - drug effects</topic><topic>Urination - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kanie, Sayoko</creatorcontrib><creatorcontrib>Yokoyama, Osamu</creatorcontrib><creatorcontrib>Komatsu, Kazuto</creatorcontrib><creatorcontrib>Kodama, Koichi</creatorcontrib><creatorcontrib>Yotsuyanagi, Satoshi</creatorcontrib><creatorcontrib>Niikura, Susumu</creatorcontrib><creatorcontrib>Nagasaka, Yasuhiro</creatorcontrib><creatorcontrib>Miyamoto, Ken-Ichi</creatorcontrib><creatorcontrib>Namiki, Mikio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kanie, Sayoko</au><au>Yokoyama, Osamu</au><au>Komatsu, Kazuto</au><au>Kodama, Koichi</au><au>Yotsuyanagi, Satoshi</au><au>Niikura, Susumu</au><au>Nagasaka, Yasuhiro</au><au>Miyamoto, Ken-Ichi</au><au>Namiki, Mikio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion</atitle><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><date>2000-10-01</date><risdate>2000</risdate><volume>279</volume><issue>4</issue><spage>1230</spage><epage>R1238</epage><pages>1230-R1238</pages><issn>0363-6119</issn><eissn>1522-1490</eissn><abstract>1  Department of Urology, Kanazawa University School of Medicine, and 2  Department of Pharmacology and Pharmaceutics, Graduate School of Natural Science and Technology, Kanazawa University, Ishikawa 920-8641, Japan To evaluate the influences of -aminobutyric acid (GABA) mechanisms on bladder hyperactivity after left middle cerebral artery occlusion, cystometric recordings were obtained from unanesthetized female rats. Intracerebroventricular administration of both muscimol (GABA A receptor agonist; 0.1-10 nmol) and baclofen (GABA B receptor agonist; 0.1-3 nmol) produced dose-dependent inhibitions of micturition with increases in bladder capacity (BC). The effects of high doses (1-10 nmol) were similar in sham-operated (SO) and cerebral-infarcted (CI) rats. However, lower doses of muscimol (0.1 or 0.3 nmol) and baclofen (0.1 nmol) reduced BC in CI rats. After bicuculline (GABA A receptor antagonist; 1 or 3 nmol) administration, BC in both SO and CI rats first decreased and subsequently increased. An increase in urethral pressure was observed after administration of bicuculline (3 nmol) but not with either muscimol or baclofen. Infarct volumes in muscimol-, bicuculline-, or baclofen-treated rats were not significantly different from those of vehicle-treated rats. These results suggest that GABAergic mechanisms inhibit the micturition reflex at the supraspinal level but that this can change as a result of CI. GABA or -aminobutyric acid; micturition reflex; cerebral infarction</abstract><cop>United States</cop><pmid>11003988</pmid><doi>10.1152/ajpregu.2000.279.4.r1230</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6119
ispartof American journal of physiology. Regulatory, integrative and comparative physiology, 2000-10, Vol.279 (4), p.1230-R1238
issn 0363-6119
1522-1490
language eng
recordid cdi_pubmed_primary_11003988
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Baclofen - administration & dosage
Baclofen - pharmacology
Bicuculline - administration & dosage
Bicuculline - pharmacology
Cerebral Infarction - physiopathology
Cerebral Ventricles - drug effects
Cerebral Ventricles - physiology
Cerebral Ventricles - physiopathology
Dose-Response Relationship, Drug
Female
GABA-A Receptor Agonists
GABA-B Receptor Agonists
Injections, Intraventricular
Middle Cerebral Artery - physiology
Muscimol - administration & dosage
Muscimol - pharmacology
Pressure
Rats
Rats, Sprague-Dawley
Seizures - physiopathology
Urinary Bladder - drug effects
Urinary Bladder - physiology
Urinary Bladder - physiopathology
Urination - drug effects
Urination - physiology
title GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A39%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GABAergic%20contribution%20to%20rat%20bladder%20hyperactivity%20after%20middle%20cerebral%20artery%20occlusion&rft.jtitle=American%20journal%20of%20physiology.%20Regulatory,%20integrative%20and%20comparative%20physiology&rft.au=Kanie,%20Sayoko&rft.date=2000-10-01&rft.volume=279&rft.issue=4&rft.spage=1230&rft.epage=R1238&rft.pages=1230-R1238&rft.issn=0363-6119&rft.eissn=1522-1490&rft_id=info:doi/10.1152/ajpregu.2000.279.4.r1230&rft_dat=%3Cproquest_pubme%3E72293182%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72293182&rft_id=info:pmid/11003988&rfr_iscdi=true